Pulmonary Pharmacology & Therapeutics

Papers
(The median citation count of Pulmonary Pharmacology & Therapeutics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)73
Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers41
CG223, a novel BET inhibitor, exerts TGF-β1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosis38
Improvement of asthma control in adult patients using extrafine inhaled beclomethasone/formoterol fixed combination as maintenance therapy as well as maintenance and reliever therapy – CONTROL study36
Shedding light on vitamin D in tuberculosis: A comprehensive review of clinical trials and discrepancies31
S1PR1 attenuates pulmonary fibrosis by inhibiting EndMT and improving endothelial barrier function26
Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patients26
The inflammatory regulation of TRPA1 expression in human A549 lung epithelial cells24
Evaluation of body weight–based dosing, alternative dosing regimens, and treatment interruptions for α1-proteinase inhibitors and implications on biochemical efficacy in patients with α1-antitrypsin d21
Editorial Board20
Pharmacokinetic variability of CFTR modulators from standard and alternative regimens20
Relative bioavailability of budesonide/glycopyrrolate/formoterol fumarate triple therapy delivered using next generation propellants with low global warming potential19
Editorial Board19
Editorial Board19
Chronic obstructive pulmonary disease and emerging ER stress-related therapeutic targets19
Characteristics of patients with severe asthma who experienced treatment failure with omalizumab18
Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis18
The tolerability and efficacy of antifibrotic therapy in patients with idiopathic pulmonary fibrosis: Results from a real-world study16
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study16
Anlotinib prove to be a potential therapy for the treatment of pulmonary fibrosis complicated with lung adenocarcinoma16
Effects of corticosteroids on Covid-19 patients: A systematic review and meta-analysis on clinical outcomes15
Real-life impact of genotype and severity of lung disease on efficacy of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis14
Mesenchymal stromal cells-based therapy in a murine model of elastase-induced emphysema: Simvastatin as a potential adjuvant in cellular homing14
Establishment of multicenter COVID-19 therapeutics preclinical test system in Republic of Korea13
Ferroptosis mediates airway epithelial E-cadherin dysfunction in LPS-induced acute lung injury12
Unveiling the protective role of sevoflurane in video-assisted thoracoscopic surgery associated-acute lung injury: Inhibition of ferroptosis12
Triple inhaled therapy in asthma: Beliefs, behaviours and doubts12
Impact on beclometasone dipropionate pharmacokinetics when switching to a low global warming potential propellant in a pressurised metered-dose inhaler11
Guanosine and uridine alleviate airway inflammation via inhibition of the MAPK and NF-κB signals in OVA-induced asthmatic mice11
Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis11
A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects11
The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant11
Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score10
Efficacy and safety of combined isoniazid-rifampicin-pyrazinamide-levofloxacin dry powder inhaler in treatment of pulmonary tuberculosis: A randomized controlled trial10
Efficacy and safety of sequential combination therapy for pulmonary arterial hypertension: A meta-analysis of Randomized-Controlled Trials10
Inhaled bronchodilators use and clinical course of adult inpatients with Covid-19 pneumonia in Spain: A retrospective cohort study9
The incidence and prognosis of other iatrogenic immunodeficiency-associated lymphoproliferative disorders of the lung related to methotrexate: A retrospective study9
Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant9
Editorial Board9
Ensifentrine approval: A milestone in the treatment of COPD9
Editorial Board9
Nebulized amphotericin B for preventing exacerbations in allergic bronchopulmonary aspergillosis: A systematic review and meta-analysis9
Corrigendum to “Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients 9
Editorial Board9
Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study8
Scoping review: The state of research on cryptogenic organizing pneumonia therapeutics8
Strongyloides venezuelensis-derived venestatin ameliorates asthma pathogenesis by suppressing receptor for advanced glycation end-products-mediated signaling8
Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma8
Bispecific domain antibody attenuates airway hyperresponsiveness and pulmonary inflammation in ovalbumin-lipopolysaccharide induced asthma model by inhibiting IL-23 and TNF-α8
Editorial Board8
Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea7
Protective effects of adipose-derived biogenic nanoparticles on the pulmonary microvascular endothelial barrier in mice with ventilator-induced lung injury via the TRPV4/ROCK1 signalling pathway7
Chronic inhaled antibiotic therapy in people with cystic fibrosis with Pseudomonas aeruginosa infection in Germany7
Repeated doses of captopril induce airway hyperresponsiveness by modulating the TRPV1 receptor in rats7
The wonders of stem cells therapeutic application towards chronic obstructive pulmonary disease7
Remote preconditioning combined with nebulized budesonide alleviate lipopolysaccharide induced acute lung injury via regulating HO-1 and NF-κB in rats7
β-sitosterol targets glucocorticoid receptor to reduce airway inflammation and remodeling in allergic asthma7
Efficacy and safety of house dust mite subcutaneous immunotherapy in polysensitized children with allergic asthma7
Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality7
Treatment of pulmonary hypertension in patients with Hereditary Hemorrhagic Telangiectasia – A case series and systematic review7
Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan7
Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: Evidence for IL-6 as a potential target against AHR in equine asthma7
Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-196
Safety and tolerability of inhaled antibiotics in patients with bronchiectasis6
The efficacy and safety of inhaled antibiotics for pneumonia: A systematic review and meta-analysis6
The impact of SARS-COV2 pandemic on the management oF IPF patients: Our narrative experience6
Association between pre-ICU aspirin administration and ARDS mortality in the MIMIC-IV database: A cohort study6
Tyvaso DPI: Drug-device characteristics and patient clinical considerations6
Editorial Board6
Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRPα expression5
Effect of daily dosing with tiotropium against methacholine induced bronchoconstriction in asthmatics5
Gentiopicroside ameliorates ovalbumin-induced airway inflammation in a mouse model of allergic asthma via regulating SIRT1/NF-κB signaling pathway5
Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis5
Which LABA/LAMA should be chosen in COPD patients in real life?5
SIRT3 alleviates sepsis-induced acute lung injury by inhibiting pyroptosis via regulating the deacetylation of FoxO3a5
Editorial Board5
Activating transcription factor 6 in the endothelial context5
Treatment of respiratory viral infections through inhalation therapeutics: Challenges and opportunities5
HDAC8-inhibitor PCI-34051-induced exosomes inhibit human bronchial smooth muscle cell proliferation via miR-381-3p mediated TGFB35
Serum dipeptidyl peptidase-4 and eosinophil cationic protein levels in patients of bronchial asthma5
Corrigendum to “Bleomycin induced lung fibrosis increases work of breathing in the mouse” [Pulm. Pharmacol.Therapeut. 25 (2012) 281-285]5
ALDH2 attenuates radiation-induced lung injury by inhibiting ROS and epithelial-mesenchymal transition mediated by the TGF-β1/Smad pathway5
Inhaled delivery of a lipid nanoparticle encapsulated messenger RNA encoding a ciliary protein for the treatment of primary ciliary dyskinesia5
The immunomodulatory effects of macrolide antibiotics in respiratory disease5
Pulmonary drug delivery for acute respiratory distress syndrome5
Preventive effect of LCZ696 on hypoxic pulmonary hypertension in rats via regulating the PI3K/AKT signaling pathway5
Medication use in people with cystic fibrosis before and after modulator therapy4
The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination4
Impact of statin treatment and exposure on the risk of chronic allograft dysfunction in Chinese lung transplant recipients4
Effects of elexacaftor-tezacaftor-ivacaftor on daily treatment burden and airflow obstruction in adults with cystic fibrosis4
Dexmedetomidine reduces IL-4 and IgE expression through downregulation of theTLR4/NF-κB signaling pathway to alleviate airway hyperresponsiveness in OVA mice4
Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat4
Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate4
The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting4
The compound artemisinin-hydroxychloroquine ameliorates bleomycin-induced pulmonary fibrosis in rats by inhibiting TGF-β1/Smad2/3 signaling pathway4
Hyperbaric oxygen therapy as an immunomodulatory intervention in COVID-19-induced ARDS: Exploring clinical outcomes and transcriptomic signatures in a randomised controlled trial4
Effects of sildenafil on right ventricle remodelling in Portopulmonary hypertension4
Comparative biochemical efficacy analysis of an alpha1-proteinase inhibitor (Glassia®) in patients with alpha-1 antitrypsin deficiency4
Effect of roflumilast on airway remodeling in asthmatic mice exposed to or not exposed to cigarette smoke: Comparison with the effect of dexamethasone4
Are short courses of antibiotic therapy as effective as standard courses for COPD exacerbations? A systematic review and meta-analysis4
Demethyleneberberine alleviates Pseudomonas aeruginosa-induced acute pneumonia by inhibiting the AIM2 inflammasome and oxidative stress4
Effect of centrally and peripherally acting GABAB agonism on the healthy human cough reflex3
Effect of functional principle, delivery technique, and connection used on aerosol delivery from different nebulizers: An in-vitro study3
A retro-inverso modified peptide alleviated ovalbumin-induced asthma model by affecting glycerophospholipid and purine metabolism of immune cells3
Editorial Board3
Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort study3
The low global warming potential propellant HFA-152a does not induce bronchoconstriction or impair mucociliary clearance3
Up-regulation of PPAR-γ involved in the therapeutic effect of icariin on cigarette smoke-induced inflammation3
Inhaled vs. intravenous vasodilators in perioperative pulmonary hypertension during chest surgery using cardiopulmonary bypass: A systematic review and meta-analysis3
Evaluation of the prophylactic effect of hydroxychloroquine on people in close-contact with patients with COVID-193
The effect of bradykinin 1 receptor antagonist BI 1026706 on pulmonary inflammation after segmental lipopolysaccharide challenge in healthy smokers3
Efficacy and safety of selexipag, an oral prostacyclin receptor agonist for the treatment of pulmonary hypertension: A meta-analysis3
Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL33
Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia3
Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-193
IRE1α/XBP-1 promotes β-catenin signaling activation of airway epithelium in lipopolysaccharide-induced acute lung injury3
Impact of beta blockers on resting respiratory rate in older adults: A cross-sectional study3
Impacts of deficiency in vitamin D derivatives on disease severity in adult bronchial asthma patients3
Sildenafil for idiopathic pulmonary fibrosis: A systematic review and meta-analysis3
Corrigendum to “Presence and function of β-adrenergic receptors in primary equine bronchial epithelia cells” [Pulm Pharmacol Ther. (2020 Apr) 61 101897] DOI: 10.1016/j.pupt.2020.1018973
0.088417053222656